Related Experiment Video

Updated: Jan 6, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.9K

Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma

Ha Young Woo1, Sung-Im DO2, Se Hoon Kim1

  • 1Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Anticancer Research
|October 2, 2019
PubMed
Abstract

Insights

Breast carcinoma cells show reduced B-cell translocation gene 1 (BTG1) expression due to promoter methylation. This epigenetic silencing highlights BTG1 as a potential biomarker and therapeutic target in breast cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • B-cell translocation gene 1 (BTG1) down-regulation is observed in breast carcinoma.
  • The underlying mechanism for BTG1 alterations in breast cancer remains unclear.

Purpose of the Study:

  • To investigate BTG1 expression levels in breast carcinoma cells.
  • To elucidate the mechanism responsible for BTG1 down-regulation, focusing on epigenetic modifications.

Main Methods:

  • Analysis of BTG1 expression (mRNA and protein) in breast carcinoma and normal cell lines using qRT-PCR and Western blot.
  • Assessment of BTG1 promoter methylation status via methylation-specific PCR (MSP).
  • Treatment of cells with a demethylating agent (5-aza-2-deoxycytidine) to evaluate the impact of methylation on BTG1 expression.

Main Results:

  • Breast carcinoma cells exhibited significantly lower BTG1 mRNA and protein levels compared to normal mammary epithelial cells.
  • The BTG1 promoter region was found to be highly methylated in the carcinoma cell lines.
  • Treatment with 5-aza-2-deoxycytidine effectively restored BTG1 expression, indicating a role for methylation.

Conclusions:

  • Epigenetic repression, specifically promoter methylation, contributes to BTG1 down-regulation in breast carcinogenesis.
  • BTG1 represents a potential diagnostic marker for breast carcinoma.
  • BTG1 emerges as a potential therapeutic target for breast cancer treatment.
Keywords:
B-cell translocation gene 1Breast carcinomapromoter methylation

More Related Videos

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp111:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

8.5K
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

10.2K

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K